The evidence points toward an overall protective effect in adult cohorts and no increase in completed suicide in younger populations.
|Articles|August 3, 2018
Mini Quiz: Borderline Personality Disorder
Author(s)Lois W. Choi-kain, MD
Listen
0:00 / 0:00
Key Takeaways
- Option C reflects that personality disorders, while clinically challenging, are treatable and should not be categorically labeled as untreatable.
- Clinician perceptions of “treatment resistance” can promote therapeutic nihilism and hinder sustained engagement, especially when countertransference is unrecognized.
Do personality disorders get a bad rap? Take the quiz and learn more.
Advertisement
The correct answer is C.
Clinicians often see patients with personality disorders as treatment resistant-and, in some cases, untreatable. While it is true that patients with personality disorders may be challenging to treat, they are treatable.
For more on this topic, see
Advertisement
Related to this article
This study compared the efficacy and tolerability of the 5 second-generation antipsychotics that are currently FDA approved as adjunctive treatments for adults with MDD.
Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
TRD often mislabels depression; learn why MDD heterogeneity demands tailored treatments and when “difficult-to-treat” fits better.
First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.
Rethink “treatment-resistant depression” by adopting difficult-to-treat depression, verifying adequate trials, and stratifying drivers like trauma and inflammation to improve outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5